Compare STRL & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STRL | BIO |
|---|---|---|
| Founded | 1955 | 1952 |
| Country | United States | United States |
| Employees | 1740 | N/A |
| Industry | Military/Government/Technical | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 10.1B |
| IPO Year | 1996 | 1994 |
| Metric | STRL | BIO |
|---|---|---|
| Price | $335.12 | $361.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | ★ $789.71 | $335.00 |
| AVG Volume (30 Days) | ★ 771.7K | 212.7K |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 13.42 | ★ 142.61 |
| EPS | ★ 15.01 | N/A |
| Revenue | $957,958,000.00 | ★ $2,583,200,000.00 |
| Revenue This Year | $71.93 | N/A |
| Revenue Next Year | $22.23 | $2.13 |
| P/E Ratio | $23.15 | ★ N/A |
| Revenue Growth | ★ 38.81 | 0.65 |
| 52 Week Low | $281.58 | $236.73 |
| 52 Week High | $1,005.68 | $396.23 |
| Indicator | STRL | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 26.83 | 45.72 |
| Support Level | N/A | $350.29 |
| Resistance Level | $469.22 | $391.87 |
| Average True Range (ATR) | 29.52 | 11.53 |
| MACD | -6.98 | 1.14 |
| Stochastic Oscillator | 1.21 | 38.10 |
Sterling Infrastructure Inc operates through subsidiaries within three segments: E-Infrastructure, Transportation, and Building Solutions in the United States, mainly across the Southern, Northeastern, Mid-Atlantic, and Rocky Mountain regions and the Pacific Islands. E-Infrastructure Solutions generates maximum revenue and provides site development and mission-critical electrical services for data centers, manufacturing, distribution centers, warehousing, and power generation. Transportation Solutions includes infrastructure and rehabilitation projects for highways, airports, ports, rail, and storm drainage systems. Building Solutions includes residential and commercial concrete foundations, parking structures, plumbing services, and surveys for new single-family residential builds.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.